H04.319 Phlegmonous dacryocystitis of unspecified lacrimal passage

Name of the Condition

• Phlegmonous Dacryocystitis of Unspecified Lacrimal Passage

Summary

Phlegmonous dacryocystitis of the unspecified lacrimal passage is a severe, suppurative inflammation of the lacrimal sac and associated passages, characterized by spreading infection and pus formation. This acute bacterial infection typically arises from obstruction of the nasolacrimal duct, trapping tears and creating a favorable environment for bacterial growth. The condition progresses rapidly, leading to significant swelling, pain, and potential systemic symptoms if untreated.

Causes

Phlegmonous dacryocystitis of the unspecified lacrimal passage is primarily caused by bacterial infection, most commonly from Staphylococcus or Streptococcus species, which thrive in stagnant tears trapped by a blocked nasolacrimal duct. The obstruction may result from congenital abnormalities, chronic inflammation, trauma, or anatomical variations affecting the lacrimal system. The infection progresses rapidly, leading to tissue destruction and pus formation within the lacrimal sac.

Risk Factors

• Chronic nasolacrimal duct obstruction or prior episodes of dacryocystitis.
• Immunocompromised states, such as diabetes or HIV.
• Recent eye or nasal surgery.
• Anatomical abnormalities of the lacrimal system.
• Bacterial colonization from adjacent sinus or nasal infections.

Symptoms

• Intense pain, swelling, and redness at the inner corner of the eye.
• Purulent (pus-like) discharge from the lacrimal punctum.
• Fever, chills, or general malaise.
• Tenderness over the lacrimal sac.
• Possible vision changes or eye irritation.

Diagnosis

Diagnosis is based on clinical presentation, including symptoms of acute infection and physical examination findings such as swelling, redness, and purulent discharge. Imaging studies, such as dacryocystography or ultrasound, may be used to assess the lacrimal system and identify obstruction. Cultures of the discharge can help identify the causative bacteria and guide antibiotic therapy.

Treatment Options

• Intravenous or oral antibiotics to target the bacterial infection.
• Warm compresses to reduce swelling and promote drainage.
• Surgical intervention, such as dacryocystorhinostomy, to relieve obstruction and prevent recurrence.
• Pain management with analgesics as needed.

Prognosis and Follow-Up

With prompt and appropriate treatment, the prognosis is generally good, though complications can occur if the infection spreads. Follow-up care is essential to monitor for resolution of symptoms and to address any underlying causes, such as anatomical abnormalities. Recurrence is possible if the nasolacrimal duct obstruction is not adequately addressed.

Complications

• Spread of infection to surrounding tissues or the orbit.
• Formation of an abscess or fistula.
• Chronic dacryocystitis or persistent obstruction.
• Vision-threatening complications, such as orbital cellulitis.

Lifestyle & Prevention

• Maintain good hygiene to reduce bacterial colonization.
• Address underlying conditions, such as allergies or sinus infections, that may contribute to duct obstruction.
• Seek prompt treatment for minor eye or nasal infections to prevent progression.
• Avoid trauma to the lacrimal system when possible.

When to Seek Professional Help

Seek immediate medical attention if you experience severe eye pain, swelling, fever, or purulent discharge, as these may indicate a serious infection requiring urgent treatment.

Tips for Medical Coders

When coding for phlegmonous dacryocystitis of the unspecified lacrimal passage, use code H04.319. Ensure documentation supports the unspecified nature of the lacrimal passage involvement and confirms the presence of suppurative inflammation. Verify that the diagnosis aligns with clinical findings and that any relevant details, such as acute bacterial infection or obstruction, are clearly documented.